AMRN: your link with form 4 by Paresh Soni VP of the company, sold all share, does not works. can you please send it again.
Based on substantial research on Amarin by this board and the many analyst's positive comment on AMRN, I only have one reservation. Namely the selling by Paresh Soni,( M.D., Ph.D., Senior Vice President and Head of Development) of virtually all his shares in AMRN. (www.secform4.com/insider-trading/1508485.htm)
Basically, he is going into the Marine result without any exposure.
I am not familiar with clinical trials but my question is basically when is the unblinding of the trial done? Would Soni be privy to this info?
Any help with regards to this would be very helpful. Thanks.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.